- Home
- RVPH vs RADX Comparison
RVPH vs RADX Comparison
Compare RVPH & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- RADX
- Stock Information
- Founded
- RVPH 2006
- RADX 2021
- Country
- RVPH United States
- RADX Australia
- Employees
- RVPH N/A
- RADX N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- RADX
- Sector
- RVPH Health Care
- RADX
- Exchange
- RVPH Nasdaq
- RADX NYSE
- Market Cap
- RVPH 32.8M
- RADX 32.5M
- IPO Year
- RVPH N/A
- RADX N/A
- Fundamental
- Price
- RVPH $0.39
- RADX $4.20
- Analyst Decision
- RVPH Strong Buy
- RADX Strong Buy
- Analyst Count
- RVPH 5
- RADX 2
- Target Price
- RVPH $9.00
- RADX $13.50
- AVG Volume (30 Days)
- RVPH 3.1M
- RADX 22.8K
- Earning Date
- RVPH 08-13-2025
- RADX 02-26-2025
- Dividend Yield
- RVPH N/A
- RADX N/A
- EPS Growth
- RVPH N/A
- RADX N/A
- EPS
- RVPH N/A
- RADX N/A
- Revenue
- RVPH N/A
- RADX $204,609.00
- Revenue This Year
- RVPH N/A
- RADX N/A
- Revenue Next Year
- RVPH N/A
- RADX N/A
- P/E Ratio
- RVPH N/A
- RADX N/A
- Revenue Growth
- RVPH N/A
- RADX N/A
- 52 Week Low
- RVPH $0.30
- RADX $3.50
- 52 Week High
- RVPH $4.28
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- RVPH 33.44
- RADX N/A
- Support Level
- RVPH $0.35
- RADX N/A
- Resistance Level
- RVPH $0.83
- RADX N/A
- Average True Range (ATR)
- RVPH 0.06
- RADX 0.00
- MACD
- RVPH -0.01
- RADX 0.00
- Stochastic Oscillator
- RVPH 17.36
- RADX 0.00
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.